Global Hyaluronic Market 2012-2016

Global Hyaluronic Market 2012-2016

Category : Pharmaceuticals

------------ Or -------------

TechNavio's analysts forecast the Global Hyaluronic Acid market to grow at a CAGR of 9.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in aging population. The Global Hyaluronic Acid market has also been witnessing the shift to shorter treatment regimens. However, the intense price competition could pose a challenge to the growth of this market. 
TechNavio's report, Global Hyaluronic Acid Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hyaluronic Acid market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Ferring Pharmaceuticals Inc., Fidia farmaceutici SpA, Sanofi SA and Seikagaku Corp.
Other vendors mentioned in the report are Anika Therapeutics Inc., Contipro Biotech Sro, htl BIOTECHNOLOGY, Lifecore Biomedical LLC, Shandong Freda Biochem Co. Ltd, Teijin Pharma Ltd., TRB Chemedica International SA and Novozymes A/S.
Key questions answered in this report: 
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology

Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

Product Offerings

06. Market Landscape

06.1 Global HAMarket

Market Size and Forecast

06.2 HA Market in the US

Market Size and Forecast

06.3 Market Segmentation by Product Type

06.4 Five Forces Analysis

07. Geographical Segmentation

08. Key Leading Countries



09. Vendor Landscape

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Key Vendor Analysis

16.1 FerringPharmacuticals Inc.

Business Overview

Key Information

SWOT Analysis

16.2 FidiaFarmaceuticiSpA

Business Overview

Key Information

SWOT Analysis

16.3 Sanofi SA

Business Overview

Key Information

SWOT Analysis

16.4 Seikagaku Corp.

Business Overview

Key Information

SWOT Analysis

17. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global HA Market 2012-2016 (US$ billion)

Exhibit 3: HA Market in the US 2012-2016 (US$ billion)

Exhibit 4: Global HA Market Segmentation based on Product Type

Exhibit 5: Business Segmentation of Ferring Pharmaceuticals Inc.

Exhibit 6: Business Segmentation of FidiaFarmaceuticiSpA

Exhibit 7: Business Segmentation of Sanofi SA

Exhibit 8: Business Segmentation of Seikagaku Corp.


Enquiry Before Buy